Sensitive ASX Announcement

Acrux's fifth generic dossier accepted by FDA for review

Published: 13/09/21, 08:22am (AEST)2 pages
Acrux Limited
ACR:ASXHealthcare

Recent ACR Announcements

Price Sensitive only